RegMed Forum 2023 | ATMPs – Thinking Big, Inclusive and Beyond Rare Disease!

BCRT (BIH Center for Regenerative Therapies)
09:00 till 16:00 o'clock
Kalendereintrag speichern
BCRT (BIH Center for Regenerative Therapies)

Charité - Universitätsmedizin Berlin

Campus Virchow-Klinikum

Föhrer Str. 15, 13353 Berlin

Current medical treatments, particularly in common diseases, often rely on chronic medication, which has its limitations. To promote healthier aging and enhance quality of life, the development of sustainable and regenerative therapies is crucial. Challenges in demonstrating proof of principle and financial constraints post-proof of principle have impeded the clinical translation and wider adoption of advanced therapies.

-> Click here for more information and registration at our event website

With the RegMed Forum we aim to identify those shortcomings that currently block or hinder advanced and regenerative therapies to become leading strategies in health care. We believe that a patient-centric view should be at the core of our discussion and, thus, the forum brings together all stakeholders involved from patient representatives, healthcare providers, regulatory authorities, scientists, start-ups and big pharma. They will share their expertise and opinions in talks, panel discussions and dedicated round tables. Furthermore, there will be plenty of networking opportunities aiming to reach a consensus understanding on the essential patient-centric outcome measures and the requirements of a patient-centric view. Such way, the implementation of advanced therapies could prove effective despite their sometimes higher initial costs.

What to expect?

  • Talks & panel discussions with different stakeholders.
  • Round table discussions in breakout-sessions on specific topics.
  • Onsite industry exhibition to present your products and services.
  • Plenty of onsite networking opportunity.

Who will be attending?

Patient representatives, healthcare providers, regulatory authorities, scientists, start-ups and big pharma from Germany and beyond interested in developing essential outcome measures and requirements in a patient-centric view that could help to support pre-clinical and clinical work to enable broader applications of advanced therapies in various indications.

The event is free of charge.